People who suffer from neurodegenerative diseases need specialist care. Join our team of students and become the best in your profession”

Patients with forms of Dementia gradually lose more and more of their abilities. For this reason, it’s necessary to provide them with more personalized and multidisciplinary care, with professionals who are able to adapt to any situation and who have the most up to date knowledge in this field. By integrating into the same theoretical framework the vision of specialists in neurology geriatrics, psychiatry, neuro-radiology, nuclear medicine and neuropathology, we are able to offer exceptional training, which is both complete and enriching. 

Basic concepts will be taught in a developing educational structure by leading professionals in their fields, in both functional and structural imaging biomarkers as well as in neuropathology, including genetic counseling and neuropsychology. We never miss the opportunity to prepare students to deal with the diagnostic process and the management of people who suffer from rapidly progressive Dementia in its different forms. In addition, students will be presented with real situations within which they need to make clinical and diagnostic decisions which are all the more complex due to their differential diagnosis and their therapeutic approach. 
The theoretical contents will be reinforced by clinical-practical cases, educational videos, online tutorials, as well as support material, always based on the latest information in the field. 

This TECH Master's Degree in Dementia is an educational project that promises to train high-quality professionals. A program devised by professionals specialized in each specific field who encounter new challenges every day.  

After completing this Master's Degree, students with have sufficient knowledge to approach the management of people with Dementia. From the first moment, they will know everything that comes with this type of disease, from its diagnosis, treatment and possible adverse effects to the importance of communication with the family members. So don't hesitate any longer and become a true professional through the latest educational technology 100% online. 

Don’t miss the opportunity to study this TECH Master's Degree in Dementia with us” It's the perfect opportunity to advance your career"

This Master's Degree in Dementia contains the most complete and up-to-date scientific program on the market. The most important features include:

• Practical case studies presented by experts in dementia
• The graphic, schematic, and practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice
• The latest information on treatment for dementia patients
• Practical exercises where self-assessment can be used to improve learning
• A special emphasis on innovative methodologies in the field of Dementia
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Content that is accessible from any fixed or portable device with an Internet connection

This Master's Degree may be the best investment you can make when selecting a refresher program, for two reasons: in addition to updating your knowledge in Dementia, you will obtain a qualification from TECH Global University"

The teaching staff includes medical professionals who bring their experience to this program, as well as renowned specialists from leading societies and prestigious universities.

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive education programmed to learn in real situations.

This program is designed around Problem-Based Learning, whereby the professional must try to solve the different professional practice situations that arise throughout the program. For this purpose, professionals will be assisted by an innovative interactive video system created by renowned and experienced experts in Dementia with extensive experience.

This training comes with the best didactic material, providing you with a contextual approach that will facilitate your learning"

This 100% online Master's Degree will allow you to combine your studies with your professional work while increasing your knowledge in this field"

The structure of the content has been designed by the best professionals in the sector, with extensive experience and recognized prestige in the profession, backed by the volume of cases reviewed, studied, and diagnosed, and with extensive knowledge of new technologies applied to teaching.

This TECH Master's Degree in Dementia contains the most complete and up-to-date scientific program on the market" 

Module 1. Alzheimer's Disease    

1.1. Concept
1.2. Epidemiology 
1.3. Risk Factors
1.4. Typical and Atypical Clinical Phenotypes
1.5. Diagnostic Criteria
1.6. Biomarkers in Alzheimer's Disease
1.7. Treatment Focused on Cognition Pharmacological and Non-pharmacological
1.8. Treatment of BPSD
1.9. Future Therapeutic Targets
1.10. Genetic Assessment

Module 2. Vascular Cognitive Impairment

2.1. Concept
2.2. Risk Factors    
2.3. Epidemiology
2.4. Diagnostic Criteria
2.5. Clinical Phenotypes
2.6. Neuropsychological Aspects 
2.7. Biomarkers in Structural Imaging
2.8. Treatment Focused on Cognition
2.9. Treatment Focused on Behavior
2.10. Non-Pharmacological Treatment

Module 3. Lewy Body Dementia

3.1. Introduction: Lewy Body Dementia Within Synucleinopathies
3.2. Epidemiology
3.3. Clinical and Radiological Diagnostic Criteria Topography of Lesions in Images and their Clinical Expression Differential Diagnosis Based on the Clinical Expression of the Topographic Lesion
3.4. Early and Late Clinical Semiology Clinical Phenotypes
3.5. Diagnostic Approach and Clinical Management of Dysautonomia and the Common Clinical Comorbidities Falls and Fractures Sleep Disorders. Behavioral Disorders    
3.6. Pharmacological Treatment Focused on Cognition
3.7. Non-Pharmacological Treatment
3.8. Treatment Focused on Motor Skills
3.9. Pharmacological and Non-pharmacological Treatment Focused on Behavior
3.10. Considerations for Advanced Decision Planning for People with Lewy Body Disease  

Module 4. Frontotemporal Dementia 

4.1. Concept
4.2. Epidemiology
4.3. Diagnostic Criteria
4.4. Specificity of Cognitive and Behavioral Symptoms

4.4.1. Cognitive Symptoms
4.4.2. Behavioral Symptoms

4.5. Clinical Sub-types 

4.5.1. Behavioral Variant FTD    
4.5.2. Language Variants
4.5.3. Motor Variants: CBD and PSP
4.5.4. FTD-ALS

4.6. Pharmacological Treatment
4.7. Non-Pharmacological Treatment

Module 5. Neuropsychology in Dementias

5.1. Neuropsychological Assessment of Attention and Memory
5.2. Neuropsychological Evaluation of Language
5.3. Neuropsychological Evaluation of Praxis
5.4. Neuropsychological Evaluation of Visual-spatial Functions
5.5. Neuropsychological Evaluation of Executive Functions
5.6. Behavioral and Functional Evaluation
5.7. Cognitive Patterns in Dementia

5.7.1. Cortical vs. Sub-cortical
5.7.2. Frontotemporal vs. Parieto-Occipital 

5.8. Cognitive Rehabilitation
5.9. Bibliographic References

Module 6. Genetic Assessment in Dementias     

6.1. Introduction
6.2. Genetics in Alzheimer's Disease

6.2.1. Prevalence
6.2.2. Mendelian Genetics
6.2.3. Susceptibility of Genes    
6.2.4. Recommendations in Clinical Practice

6.3. Genetics in Vascular Dementia 

6.3.1. Recommendations in Clinical Practice

6.4. Genetics in Fronto-temporal Dementia

6.4.1. Genetics of BVFTD
6.4.2. Genetics in FTD with Parkinsonism
6.4.3. Genetics in FTD-ALS
6.4.4. Genetics of Primary Aphasia
6.4.5. Clinical-Genetic Correlations
6.4.6. Recommendations in Clinical Practice

6.5. Genetics of Prion Diseases

6.5.1. Recommendations in Clinical Practice

6.6. Diagnostic Algorithm

6.6.1. Diagnostic Algorithm in Alzheimer's Disease
6.6.2. Diagnostic Algorithm in FTD

6.7. Genetic Counseling

6.7.1. Concept of Genetic Counseling
6.7.2. Practical Examples PSEN 1 Gene, C9ORF72 Gene, APOE4 Gene, CADASIL Cases, Progranulin Gene

Module 7. Molecular Neuroimaging in Dementias

7.1. Introduction    
7.2. Methodological Aspects

7.2.1. Equipment SPECT and PET
7.2.2. Molecular Processes and Radiopharmaceuticals

7.2.2.1. Neuron Activity
7.2.2.2. Dopaminergic Activity
7.2.2.3. Amyloid Deposition
7.2.2.4. Tau Deposit
7.2.2.5. Neuroinflammation

7.2.3. Image Analysis

7.2.3.1. Visual Analysis
7.2.3.2. Comparison with a Normal Database in Stereostatic Surface Projection (SSP)
7.2.3.3. Voxel-Based Image Analysis

7.3. Neuroimaging of Alzheimer’s Disease

7.3.1. Mild Cognitive Impairment and Dementia
7.3.2. Atypical Forms

7.4. Neuroimaging in Fronto-temporal Dementia

7.4.1. FTD Variant in Behavior
7.4.4. Primary Aphasias
7.4.3. Others

7.5. Neuroimaging of Dementias with Parkinsonism

7.5.1. Lewy Body Dementia
7.5.2. Progressive Supranuclear Palsy
7.5.3. Corticobasal Degeneration

7.6. Diagnostic Algorithm

7.6.1. Diagnostic Algorithm in Alzheimer's Disease
7.6.2. Diagnostic Algorithm in FTD and Dementia with Parkinsonism

7.7. Case Studies

Module 8. MRI in Dementias

8.1. Introduction
8.2. Diagnostic Algorithm

8.2.1. CT and MRI in Cognitive Impairment Evaluation Classification of Dementias
8.2.2. White Matter Evaluation
8.2.3. Gray Matter Evaluation
8.2.4. Advanced Techniques: Perfusion, Diffusion, Spectroscopy, Functional MRI

8.3. Potentially Treatable Causes of Dementia

8.3.1. Adult Hydrocephalus, Vascular Injuries
8.3.2. Surgical Injuries: Tumors and Subdural Hematoma
8.3.3. Inflammatory and Infectious Lesions

8.4. Alzheimer’s Disease.

8.4.1. Structural MRI: Typical and Atypical Phenotypes
8.4.2. Volumetry: Cortical Thickness and Hippocampi
8.4.3. Perfusion Techniques: Differential Diagnosis
8.4.4. Progression Markers

8.5. Vascular Dementia

8.5.1. Small Vessel Disease
8.5.2. Multi-infarct Dementia
8.5.3. Microhemorrhages SWI Imaging

8.6. Other Degenerative Dementias

8.6.1. Frontotemporal Dementia
8.6.2. Lewy Body Dementia

8.7. Future Perspectives

8.7.1. Functional MRI and Brain Networks
8.7.2. Neuroimaging and Artificial Intelligence

Module 9. Neuropathology in Dementias     

9.1. Introduction

9.1.1. Delimitation of the Scope of the Study    
9.1.2. Pathogenic Axis for the Interpretation of Histological Findings
9.1.3. Sporadic vs. Genetic Diseases 
9.1.4. Diagnostic Criteria vs. Neuropathological Findings

9.2. Levels of Study in Neuropathology

9.2.1. Macroscopic
9.2.2. Histological
9.2.3. Molecular

9.3. Alzheimer's Type Pathology

9.3.1. Macroscopic Findings
9.3.2. Characteristics of Histological Lesions
9.3.3. Beta Amyloid Pathology    
9.3.4. TAU Pathology
9.3.5. Diagnostic Criteria and Stages    

9.4. Lewy Type Pathology

9.4.1. Macroscopic Findings
9.4.2. Characteristics of Histological Lesions    
9.4.3. Lewy Body Dementia: Stages and Subtypes    
9.4.4. Lewy Disease as a Combined Pathology

9.5. Tauopathies with Dementia

9.5.1. Molecular Classification of Tauopathies
9.5.2. Progressive Supranuclear Palsy
9.5.3. Argyrophilic Grain Disease
9.5.4. Corticobasal Degeneration
9.5.5. Pick Disease
9.5.6. Other Less Common Tauopathies
9.5.7. Combined Pathology Tauopathies

9.6. Pathology TDP-43

9.6.1. FTLD TDP-43 Classification
9.6.2. Sporadic FTLD
9.6.3. Genetics in FTLD
9.6.4. Hippocampal Sclerosis and LATE

9.7. Rare FTLD and Other Uncommon Pathologies as a Cause of Neurodegenerative Dementia 
9.8. Human Prion Diseases

9.8.1. Molecular Pathology of the Prionic Protein
9.8.2. Sporadic Creutzfeldt-Jakob Disease: Molecular Subtypes
9.8.3. Genetic Prionic Diseases
9.8.4. Transmissible Prion Diseases

9.9. Cerebrovascular Pathology and Dementia

9.9.1. Basic Lesions and Assessment Strategy
9.9.2. Post-infarction Dementia
9.9.3. Dementia and Small Vessel Pathology
9.9.4. Cerebrovascular Disease as a Combined Pathology

Module 10. Rapidly Progressive Dementias

10.1. Introduction

10.1.1. Concept 
10.1.2. Epidemiology 
10.1.3. Differential Diagnosis and Diagnostic Algorithm 

10.2. Prion Diseases

10.2.1. Sporadic Creutzfeldt-Jakob Disease 
10.2.2. Other Prionopathies: Variant CJD, Gerstmann-Sträussler, Fatal Familial Insomnia, etc.

10.3. Infections

10.3.1. HIV 
10.3.2. Syphilis 
10.3.3. Other Infections of the Central Nervous System (Viral Encephalitis, PML, Subacute-Chronic Meningitis) 

10.4. Autoimmune Diseases

10.4.1. Antibody-mediated Encephalitis
10.4.2. Hashimoto
10.4.3. Vasculitis of the Central Nervous System
10.4.4. Others (Sarcoidosis, Systemic Vasculitis, etc.)

10.5. Oncology Patients

10.5.1. Tumors of the Central Nervous System
10.5.2. Meningeal Carcinomatosis
10.5.3. Yatrogen (Radiotherapy, Intrathecal Chemotherapy)

10.6. Toxic-Metabolic

10.6.1. Endocrinopathies
10.6.2. Carential
10.6.3. Mitochondrial
10.6.4. Toxic (Alcohol, Metal, Drugs)

Module 11. Comprehensive Geriatric Assessment of the Elderly Person Suffering from Cognitive Impairment or Dementia Clinical and Cognitive Comorbidities Some Aspects of the Advanced Planning with Impact the Clinical Evolution

11.1. Introduction: Eldery Patients with Cognitive Impairment Dementia and the Functional Perspective
11.2. Comorbidities: Elderly Patients Who Suffer From Comorbid Pathologies Which Influence Neurodegeneration and Comorbid Pathologies Which Are Related to Non-Dementia Cognitive Impairment    

11.2.1. Polypharmacy and Overprescription
11.2.2. Falls, Walking and Cognition Joint Evaluation of Both Entities
11.2.3. Frailty and Sarcopenia Prescribed Exercise in Elderly People with Cognitive Impairment
11.2.4. Anorexia, Dysphagia, Weight Loss and Refusal to Eat Interaction with Cognitive Impairment and Clinical Evolution
11.2.5. Other Geriatric Syndromes
11.2.6. Considerations of Advanced Planning of Care and Decision Making in Elderly Patients Who Suffer From Cognitive Impairment and Dementia

This program will allow you to advance comfortably in your career"